Premium
Leukapheresis for control of chronic myelogenous leukemia during pregnancy
Author(s) -
Fitzgerald Denis,
Rowe Jacob M.,
Heal Joanna
Publication year - 1986
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830220213
Subject(s) - leukapheresis , medicine , pregnancy , chronic myelogenous leukemia , chemotherapy , leukemia , obstetrics , surgery , immunology , stem cell , genetics , cd34 , biology
Leukapheresis was used as the sole modality of treatment of a patient with chronic myelogenous leukemia (CML) during her pregnancy. The specific requirements for safe leukapheresis during pregnancy are discussed, and the literature describing the management of CML during pregnancy is reviewed. Leukapheresis may be the treatment of choice in selected pregnancy patients with CML since it avoids the potential teratogenic effects of chemotherapy or radiation therapy.